<?xml version='1.0' encoding='utf-8'?>
<document id="26566368"><sentence text="Rationale and clinical utility of the darunavir-cobicistat combination in the treatment of HIV/AIDS."><entity charOffset="38-47" id="DDI-PubMed.26566368.s1.e0" text="darunavir" /></sentence><sentence text="This article is to provide an update overview of cobicistat (COBI)-boosted darunavir in response to its recent approval by the US Food and Drug Administration, and inclusion as an alternative first-line regime in the 2015 treatment guidelines in the US" /><sentence text=" COBI is a relatively new non-antiretroviral cytochrome P450 3A inhibitor or pharmacoenhancer" /><sentence text=" The rationale behind COBI development was to provide an alternative to ritonavir (RTV) as a protease inhibitor pharmacoenhancer, due to associated adverse events with short- and long-term RTV use, such as gastrointestinal intolerability, drug-drug interactions, insulin resistance, lipodystrophy, and hyperlipidemia"><entity charOffset="72-81" id="DDI-PubMed.26566368.s4.e0" text="ritonavir" /></sentence><sentence text=" Although in vitro studies suggest that COBI may result in a lower incidence of undesired drug-drug interactions and lipid-associated disorders than RTV, not all Phase III studies have well addressed these issues, and the data are limited" /><sentence text=" However, Phase III studies have demonstrated tolerability, noninferiority, and bioequivalence of COBI compared to RTV" /><sentence text=" Two main advantages of COBI over RTV-containing regimes have been noted as follows: 1) COBI has no anti-HIV activity; therefore, resistance to COBI as a booster in addition to protease inhibitor resistance is of little concern, allowing for COBI-containing regimes in future"><entity charOffset="242-246" id="DDI-PubMed.26566368.s7.e0" text="COBI" /><entity charOffset="24-27" id="DDI-PubMed.26566368.s7.e1" text="COBI" /><entity charOffset="88-91" id="DDI-PubMed.26566368.s7.e2" text="COBI" /><entity charOffset="144-147" id="DDI-PubMed.26566368.s7.e3" text="COBI" /><pair ddi="false" e1="DDI-PubMed.26566368.s7.e1" e2="DDI-PubMed.26566368.s7.e1" /><pair ddi="false" e1="DDI-PubMed.26566368.s7.e1" e2="DDI-PubMed.26566368.s7.e2" /><pair ddi="false" e1="DDI-PubMed.26566368.s7.e1" e2="DDI-PubMed.26566368.s7.e3" /><pair ddi="true" e1="DDI-PubMed.26566368.s7.e1" e2="DDI-PubMed.26566368.s7.e0" /><pair ddi="false" e1="DDI-PubMed.26566368.s7.e2" e2="DDI-PubMed.26566368.s7.e2" /><pair ddi="false" e1="DDI-PubMed.26566368.s7.e2" e2="DDI-PubMed.26566368.s7.e3" /><pair ddi="true" e1="DDI-PubMed.26566368.s7.e2" e2="DDI-PubMed.26566368.s7.e0" /><pair ddi="false" e1="DDI-PubMed.26566368.s7.e3" e2="DDI-PubMed.26566368.s7.e3" /><pair ddi="true" e1="DDI-PubMed.26566368.s7.e3" e2="DDI-PubMed.26566368.s7.e0" /></sentence><sentence text=" 2) COBI's solubility and dissolution rate allow for co-formulated/fixed-dose combination products"><entity charOffset="4-7" id="DDI-PubMed.26566368.s8.e0" text="COBI" /></sentence><sentence text=" Nonetheless, prior to initiating COBI-containing treatment regimens, the following should be considered: 1) COBI may increase serum creatinine levels and reduce estimated glomerular filtration rate (GFR) without affecting actual GFR; 2) potential drug-drug interaction data are insufficient, warranting caution when initiating COBI in conjunction with concomitant medication or in individuals with multiple comorbidities; 3) food plays a pivotal role in boosting darunavir exposure, warranting caution and patient education on the importance of taking COBI-containing regimens with appropriate amounts of food; and 4) data on the success of COBI-containing regimens in treatment-experienced patients are limited"><entity charOffset="34-38" id="DDI-PubMed.26566368.s9.e0" text="COBI" /><entity charOffset="133-143" id="DDI-PubMed.26566368.s9.e1" text="creatinine" /><entity charOffset="328-332" id="DDI-PubMed.26566368.s9.e2" text="COBI" /><entity charOffset="464-473" id="DDI-PubMed.26566368.s9.e3" text="darunavir" /><entity charOffset="553-557" id="DDI-PubMed.26566368.s9.e4" text="COBI" /><entity charOffset="109-112" id="DDI-PubMed.26566368.s9.e5" text="COBI" /><entity charOffset="642-645" id="DDI-PubMed.26566368.s9.e6" text="COBI" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e0" e2="DDI-PubMed.26566368.s9.e0" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e0" e2="DDI-PubMed.26566368.s9.e5" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e0" e2="DDI-PubMed.26566368.s9.e1" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e0" e2="DDI-PubMed.26566368.s9.e2" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e0" e2="DDI-PubMed.26566368.s9.e3" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e0" e2="DDI-PubMed.26566368.s9.e4" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e0" e2="DDI-PubMed.26566368.s9.e6" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e5" e2="DDI-PubMed.26566368.s9.e5" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e5" e2="DDI-PubMed.26566368.s9.e1" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e5" e2="DDI-PubMed.26566368.s9.e2" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e5" e2="DDI-PubMed.26566368.s9.e3" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e5" e2="DDI-PubMed.26566368.s9.e4" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e5" e2="DDI-PubMed.26566368.s9.e6" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e1" e2="DDI-PubMed.26566368.s9.e1" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e1" e2="DDI-PubMed.26566368.s9.e2" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e1" e2="DDI-PubMed.26566368.s9.e3" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e1" e2="DDI-PubMed.26566368.s9.e4" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e1" e2="DDI-PubMed.26566368.s9.e6" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e2" e2="DDI-PubMed.26566368.s9.e2" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e2" e2="DDI-PubMed.26566368.s9.e3" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e2" e2="DDI-PubMed.26566368.s9.e4" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e2" e2="DDI-PubMed.26566368.s9.e6" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e3" e2="DDI-PubMed.26566368.s9.e3" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e3" e2="DDI-PubMed.26566368.s9.e4" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e3" e2="DDI-PubMed.26566368.s9.e6" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e4" e2="DDI-PubMed.26566368.s9.e4" /><pair ddi="false" e1="DDI-PubMed.26566368.s9.e4" e2="DDI-PubMed.26566368.s9.e6" /></sentence><sentence text=" " /></document>